AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients

Botulinum neurotoxin type-A (BoNT-A) blocks the release of acetylcholine from peripheral cholinergic nerve terminals and is an important option for the treatment of disorders characterised by excessive cholinergic neuronal activity. Several BoNT-A products are currently marketed, each with unique ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Field, Malgorzata, Splevins, Andrew, Picaut, Philippe, van der Schans, Marcel, Langenberg, Jan, Noort, Daan, Foster, Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316182/
https://www.ncbi.nlm.nih.gov/pubmed/30551641
http://dx.doi.org/10.3390/toxins10120535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316182/
https://www.ncbi.nlm.nih.gov/pubmed/30551641
http://dx.doi.org/10.3390/toxins10120535

Ejemplares similares